Ida Fortini
Overview
Explore the profile of Ida Fortini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
81
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Almeida G, de Araujo R, Castrillo B, Silva G, Fortini I, Goncalves M, et al.
J Neuroimmunol
. 2024 Jan;
388:578295.
PMID: 38280268
Therapeutic plasma exchange (TPE) can improve disability recovery after neuromyelitis optica spectrum disease (NMOSD) attacks, but its effectiveness and safety in Latin-American patients with access barriers and diverse ethnicity is...
2.
Terrim S, Silva G, de Sa E Benevides Falcao F, Pereira C, Benassi T, Fortini I, et al.
J Neuroimmunol
. 2023 Jun;
381:578140.
PMID: 37364518
Optic neuritis (ON) admits diverse differential diagnoses. Petzold proposed diagnostic criteria for ON in 2022, although real-world application of these criteria is missing. We conducted a retrospective review of patients...
3.
Silva G, Terrim S, Falcao F, Falcao M, Chaves C, Apostolos-Pereira S, et al.
Mult Scler Relat Disord
. 2023 May;
75:104737.
PMID: 37156037
Background: Optic neuritis (ON), a major cause of visual impairment in young adults, is generally associated with rapid visual recovery when treated with intravenous methylprednisolone treatment (IVMPT). However, the optimal...
4.
Santos P, Melhado E, Kaup A, Costa A, Roesler C, Piovesan E, et al.
Arq Neuropsiquiatr
. 2022 Oct;
80(9):953-969.
PMID: 36257618
Background: Migraine affects 1 billion people worldwide and > 30 million Brazilians; besides, it is an underdiagnosed and undertreated disorder. Objective: The need to disseminate knowledge about the prophylactic treatment...
5.
Melhado E, Santos P, Kaup A, Costa A, Roesler C, Piovesan E, et al.
Arq Neuropsiquiatr
. 2022 Oct;
80(8):845-861.
PMID: 36252594
The Brazilian Headache Society (Sociedade Brasileira de Cefaleia, SBCe, in Portuguese) nominated a Committee of Authors with the aim of establishing a consensus with recommendations regarding prophylactic treatment for episodic...
6.
Portes Souza M, Costa B, Santos F, Fortini I
Arq Neuropsiquiatr
. 2022 Aug;
80(5 Suppl 1):227-231.
PMID: 35976300
Background: Idiopathic Intracranial Hypertension (IIH) is a secondary headache with a steadily growing incidence. Currently, there is little evidence to guide the treatment of IIH. Objective: To review the pathophysiology...
7.
Fortini I, Felsenfeld Junior B
Arq Neuropsiquiatr
. 2022 Aug;
80(5 Suppl 1):204-213.
PMID: 35976296
Obesity and headache disorders are two very common conditions in the general population that have been increasing in incidence over the last decades. Recent studies have shown a significant relationship...
8.
Bossoni A, Peres M, da Costa Leite C, Fortini I, Conforto A
Cephalalgia
. 2022 Jul;
42(14):1476-1486.
PMID: 35899769
Background: Headache is the most frequent symptom of cerebral venous thrombosis (CVT) but there is limited information about the frequency and phenotype of headache, weeks to months after cerebral venous...
9.
Tuma R, Guedes B, Carra R, Iepsen B, Rodrigues J, Camelo-Filho A, et al.
Neurol Sci
. 2021 Jan;
42(2):479-489.
PMID: 33409828
Objective: To describe the clinical, neurological, neuroimaging, and cerebrospinal fluid (CSF) findings associated with encephalopathy in patients admitted to a COVID-19 tertiary reference center. Methods: We retrospectively reviewed records of...
10.
Lopes C, Brucki S, Passos Neto C, Corazza L, Baima J, Fiorentino M, et al.
Arq Neuropsiquiatr
. 2020 Dec;
78(12):805-810.
PMID: 33295423
Background: Neurological manifestations of COVID-19 are still incompletely understood. Neurological manifestations may be due to direct viral effect on neurons and glial cells, to an immune-mediated response to the virus,...